ORLANDO ‑- Cataract surgery was linked to an increased risk of conversion from dry to neovascular (wet) age-related macular degeneration (AMD) in a large retrospective cohort study, although the ...

There's been extensive debate over the risk of neovascular age-related macular degeneration (AMD) after cataract surgery. In a large retrospective cohort study, the risk of neovascular AMD was similar ...

4D-150 demonstrated robust and durable clinical activity across all wet age-related macular degeneration (wet AMD) patient populations based on longest available follow-up data In broad population ...

Age-related macular degeneration (AMD) remains a leading cause of vision loss globally, with significant advancements in treatment options for both dry and wet AMD. As highlighted by Huang and ...

Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and improve vision outcomes for patients with wet AMD ARTEMIS ...

Outlook Therapeutics, Inc. has announced a key development in the treatment of wet age-related macular degeneration (wet AMD) with the National Institute for Health and Care Excellence (NICE) ...

Please provide your email address to receive an email when new articles are posted on . Genentech plans to reintroduce Susvimo for the treatment of wet age-related macular degeneration. The company is ...

Wet AMD in its early stages can be treated with drugs to reduce the formation of new blood vessels, but this treatment is inefficient in cases where blood vessel formation is already in its advanced ...

Cataract surgery was not associated with neovascular ("wet") age-related macular degeneration (nAMD), even among patients with pre-existing cases of non-neovascular ("dry") AMD, according to a large ...